INTRODUCTION
============

In the past decades, biochemical studies of individual 3′ processing factors have contributed greatly to our understanding of the molecular mechanisms underlying the maturation of mRNA 3′ ends. 3′ end processing of almost all eukaryotic mRNAs, with the exception of metazoan histone mRNAs, consists of two tightly coupled steps: hydrolysis of a phosphodiester bond, referred to as cleavage, and addition of a polyadenylate tail to the 3′ hydroxyl of the upstream cleavage product. This relatively simple process is mediated by a very elaborate set of proteins, which bind to specific sequences on the pre-mRNA and, once assembled correctly, direct cleavage at the correct location (reviewed in [@b41-molcell-37-9-644]; [@b61-molcell-37-9-644]). The core machinery includes four multi-subunit protein complexes ([Fig. 1](#f1-molcell-37-9-644){ref-type="fig"}) (reviewed in [@b30-molcell-37-9-644]): cleavage and polyadenylation specificity factor (CPSF), cleavage stimulation factor (CstF), cleavage factors I and II (CFI and CFII) as well as additional proteins such as PAP (poly(A)polymerase), symplekin, the C-terminal domain of the RNA polymerase II largest subunit (CTD) and other newly characterized factors discussed below. The most conserved ciselement, the AAUAAA sequence, is located upstream of the cleavage site, and is recognized by CPSF; variants of this motif are frequently associated with alternative usage of poly(A) sites. Downstream of the cleavage site is a G/U-rich element, which is recognized by CstF. A third element, with the consensus UGUA, is often present in one or more copies upstream of the AAUAAA, and is recognized by CFI ([@b17-molcell-37-9-644]).

More than 70% of human genes encode primary transcripts that contain multiple polyadenylation sites (PASs) (reviewed in [@b10-molcell-37-9-644]; [@b12-molcell-37-9-644]; [@b54-molcell-37-9-644]). These can be found either in internal introns, and therefore alternative polyadenylation (APA) will be coupled to alternative splicing producing different protein isoforms, or, more frequently, exclusively in the 3′ untranslated region (UTR), resulting in transcripts encoding the same proteins but with 3′ UTRs of different length, which can in turn affect the stability, localization, transport and translational properties of the mRNA. It is interesting that differential processing at multiple PASs can occur globally, and can be influenced by conditions such as differentiation and development, or by pathological conditions such as cancer ([@b18-molcell-37-9-644]; [@b20-molcell-37-9-644]; [@b27-molcell-37-9-644]; [@b31-molcell-37-9-644]; [@b46-molcell-37-9-644]). Determining how changes in APA contribute to different physiological states is a major question for future research.

The complexity of the 3′ processing machinery has already suggested a number of links to other cellular processes. In this review we will discuss how several newly characterized proteins associated with the 3′ processing complex provide additional connections with various nuclear pathways and pathological conditions, such as splicing, DNA damage, transcription and cancer.

NEW ADDITIONS TO THE HUMAN CORE 3′ PROCESSING COMPLEX
=====================================================

A few years ago, novel insights into the make-up of the polyadenylation complex were obtained from a purification and proteomic analysis of the entire 3′ processing complex in its functional form ([@b48-molcell-37-9-644]). The complex was purified at the "post-assembly" stage, after the complex had assembled on a substrate RNA but before any significant processing had occurred. Glycerol gradient sedimentation combined with RNA tag-based affinity purification led to identification of \~85 proteins that associated with substrates with intact processing signals, but not with RNAs containing AAUAAA mutations. These in cluded nearly all previously identified 3′ processing factors, with the exception of Clp1, a component of CFII. In fact, the other identified CFII subunit, Pcf11, was barely detectable, indicating that CFII may associate with the complex only transiently. CFII is the least understood of the 3′ cleavage factors: Pcf11 interacts with the RNA polymerase II CTD and is involved in transcription termination ([@b33-molcell-37-9-644]), while Clp1 has been reported to have an RNA 5′-kinase activity that is important for tRNA splicing and activation of siRNAs ([@b60-molcell-37-9-644]). Therefore, even if not tightly associated with the 3′ processing complex, the function of CFII might be critical in connecting 3′ processing to other nuclear pathways.

The canonical PAP (PAPα) was also absent from the proteins purified with the 3′ complex. This suggests that it might be recruited at a later stage, which is in fact consistent with the earliest biochemical fractionation studies ([@b52-molcell-37-9-644]), or that another related protein might have taken its place. In this regard, it is interesting that PAPγ (also known as neoPAP; [@b55-molcell-37-9-644]) was found to associate with the complex, although at low levels, indicating that PAPα and PAPγ may play redundant roles. A recent crystal structure of PAPγ shows that it shares a conserved catalytic binding pocket while residues at the surface are more divergent ([@b63-molcell-37-9-644]). The diversity in the C-terminal domain of these two proteins could contribute to differential regulation, as this region is known to be critical for regulation of PAPα activity through post-translational modifications (e.g., [@b7-molcell-37-9-644]; [@b57-molcell-37-9-644]), and distinct isoforms can be produced that result from alternative splicing that affects this region ([@b67-molcell-37-9-644]). Interestingly, PAPα has been reported to be phosphorylated throughout the cell cycle and downregulated by hyper-phosphorylation during M phase ([@b7-molcell-37-9-644]) while PAPγ did not show evidence of phosphorylation or alternative isoforms ([@b55-molcell-37-9-644]).

An additional protein that was identified in the proteomic analysis mentioned above is CstF64 tau, a conserved paralog of CstF64. CstF64 tau was shown initially to be expressed specifically in the testis and brain ([@b59-molcell-37-9-644]) and has been reported to mediate tissue-specific APA regulation ([@b28-molcell-37-9-644]). However, its presence in the 3′ complex purified from HeLa cells hinted to a more general role in polyadenylation. Indeed, a recent study showed that CstF64 tau is widely expressed in mammalian tissues and has a similar RNA-binding pattern as CstF64 *in vitro* and *in vivo* ([@b65-molcell-37-9-644]). Also, the two proteins play redundant roles in alternative polyadenylation (APA) regulation such that depletion of either induces up-regulation of the other resulting in few changes in APA, but codepletion leads to greater APA changes ([@b64-molcell-37-9-644]). Nonetheless, a significant difference between CstF64 and CstF64 tau is that the former binds symplekin with much higher affinity than the latter ([@b65-molcell-37-9-644]). Both proteins contain a "hinge" domain, initially shown to mediate CstF64 binding to symplekin ([@b51-molcell-37-9-644]), and both paralogs bind symplekin in vitro. However, the interaction with CstF64 tau is inhibited by its C-terminal Pro-Gly rich domain, which is the most divergent region between the two proteins. It is therefore possible that their association with the 3′ processing complex might be modulated by differential protein-protein interactions that depend on the Pro-Gly rich region, and these interactions, in turn, might reflect distinct functions in some aspects of mRNA 3′ processing.

The proteomic purification of the 3′ complex led to the identification of three proteins that were not previously implicated in mRNA 3′ processing in mammals but are related to known yeast 3′ processing factors: PP1, WDR33 and RBBP6 ([Fig. 2](#f2-molcell-37-9-644){ref-type="fig"}); each of these proteins is discussed below.

PP1
===

PP1 is a serine/threonine phosphatase homologous to Glc7, which in yeast is known to play a role in poly(A) synthesis but not cleavage ([@b16-molcell-37-9-644]). Depletion of Glc7 in yeast has been shown to cause shortened poly(A) tails *in vivo*; similarly, [@b48-molcell-37-9-644] showed that HeLa nuclear extract (NE) depleted of PP1 displayed inhibited poly(A) synthesis activity, which could be restored by adding back recombinant PP1. Glc7 dephosphorylates Pta1 ([@b16-molcell-37-9-644]) and therefore PP1 is likely to dephosphorylate symplekin, the mammalian homolog of Pta1. Since symplekin acts as a scaffolding protein in the 3′ complex, it is possible that different states of phosphorylation of symplekin might affect its ability to interact with CPSF/CstF, ultimately modulating the efficiency of 3′ end formation. However, the phosphorylation status of symplekin is currently unknown.

Given the presence of PP1, it is not surprising that the PP1 regulatory protein, PNUTS, was found in the 3′ complex as well. PNUTS is known to form a stable complex with PP1 in mammalian cell extracts and has been shown to inhibit its catalytic activity ([@b23-molcell-37-9-644]). In addition, PNUTS has been shown to bind RNA in vitro ([@b23-molcell-37-9-644]), raising the possibility that PNUTS could have a direct function in recruiting PP1 to the 3′ complex.

PP1 is a multifunctional protein that plays a role in regulating different aspects of mRNA maturation. For example, PP1 is known to be required for the second step of pre-mRNA splicing, targeting specific snRNP proteins ([@b47-molcell-37-9-644]), while in yeast, Glc7 functions in mRNA export, through dephosphorylation of Npl3 ([@b13-molcell-37-9-644]). Future studies will reveal if PP1 can function to bridge 3′ end formation with such activities as splicing and mRNA export in mammalian cells.

WDR33
=====

Another core subunit not identified in the mammalian 3′ processing complex until the above mentioned proteomics analysis is WDR33. Its size is similar to CPSF160 and this might explain why this protein previously escaped detection in other proteomic analyses that used only SDS-PAGE as a mean to separate proteins. The main characteristic of WDR33 are the seven WD40 repeats in its N-terminus, a domain that is present in proteins involved in a wide range of cellular processes, as well as in the 3′ factor CstF50. The underlying common function of most WD40-repeat proteins is that they coordinate multi-protein complex assemblies, where the repeating units serve as a scaffold for protein interactions ([@b62-molcell-37-9-644]). In addition, WD40 domains have also been reported to bind both ubiquitin ([@b39-molcell-37-9-644]) and phosphorylated Ser/Thr residues ([@b42-molcell-37-9-644]). The yeast homolog of WDR33 is Pfs2, which has been shown to be essential for 3′ processing and might play a role in tethering the yeast CPF and CFIA complexes together ([@b38-molcell-37-9-644]). Similarly to Pfs2, WDR33 was shown to interact with CPSF components and its depletion from HeLa NE abolished both cleavage and polyadenylation ([@b48-molcell-37-9-644]). It remains to be determined if WDR33 coordinates the interaction between CstF and CPSF in mammalian cells the same way as Pfs2 does in yeast. For the future it will also be of interest to investigate whether the WD40 domain has a role in mediating the interaction of WDR33 with the other 3′ factors and if this implicates Ser/Thr phosphorylated residues in the binding partners.

RBBP6
=====

The third protein identified in the purification of the mammalian 3′ complex that shares homology with a known yeast 3′ processing factor is RBBP6. Its yeast counterpart is Mpe1, which is an essential gene. Mpe1 is an integral subunit of CPF (cleavage and polyadenylation factor) and is required for both cleavage and polyadenylation ([@b58-molcell-37-9-644]). RBBP6 was first identified in 1995 as a protein that interacts with the tumor suppressor Rb ([@b45-molcell-37-9-644]) and later was shown to bind another tumor suppressor, p53 ([@b49-molcell-37-9-644]). The \~250 KD RBBP6 shares with Mpe1 three conserved domains in its N-terminus but has a unique long C-terminal extension that mediates the binding to p53 and Rb, raising the possibility that it may have a potential role in integrating 3′ processing with these nuclear pathways. RBBP6 is able to regulate 3′ processing and it associates with the 3′ processing complex through a ubiquitin-like domain called DWNN (domain with no name). This domain is required for 3′ processing activity and is also expressed as a single domain protein (isoform3). Isoform3, which is down regulated in several cancers ([@b32-molcell-37-9-644]), inhibits pre-mRNA 3′ end cleavage by competing with the full-length RBBP6 for binding the core machinery ([Fig. 3A](#f3-molcell-37-9-644){ref-type="fig"}) (Di Giammartion, D.C., Ogami, K., Li, W., Yashinskie, J.J., Hoque, M., Tian, B., and Manley, J.L., unpublished data). In the future it will be particularly interesting to better understand if isoform3 can indeed function as a ubiquitin-like modifier and if this new type of modification is involved in regulating 3′ processing, for example by covalently attaching to core 3′ processing factors, thereby affecting their function. In addition, genome-wide analyses revealed that, following RBBP6 knockdown, there is a general lengthening in 3′UTRs and a downregulation in mRNAs levels, in particular of transcripts with AU-rich 3′UTRs. More work is required to understand the molecular mechanism that underlies this specificity.

OTHER NUCLEAR PROTEINS ASSOCIATED WITH THE 3′ COMPLEX
=====================================================

In addition to the known core 3′ processing factors and the other proteins discussed above, the proteomic analysis of the 3′ complex allowed detection of about fifty proteins that co-purified with the active complex ([@b48-molcell-37-9-644]) ([Fig. 2](#f2-molcell-37-9-644){ref-type="fig"}). These include splicing factors such as U2AF65 and U1-70K, which were already found to mediate crosstalk between splicing and 3′ processing ([@b3-molcell-37-9-644]; [@b15-molcell-37-9-644]; [@b56-molcell-37-9-644]) and additional splicing factors that have not been shown yet to take part in 3′ processing. Among them are several proteins that bind the pre-mRNA at the 3′ splice site and participate in the assembly of early spliceosomal complexes, for example SF1, which binds to the branch point sequence ([@b5-molcell-37-9-644]) and several subunits of the multiprotein complexes SF3a and SF3b, which are part of the U2 snRNP that bind in close proximity of the branch point ([@b14-molcell-37-9-644]). Finding these factors in the active 3′ processing complex confirms the physical interaction between the polyadenylation and splicing machineries and may indicate that these proteins play a role in coupling splicing, for example of the terminal intron, to polyadenylation.

The tumor suppressor Cdc73 is a component of the RNA pol II-associated PAF complex and was found to associate with the 3′ processing complex as well. Around the same time a biochemical study was published which indeed confirmed that Cdc73 functionally associates with CPSF and CstF ([@b43-molcell-37-9-644]). It was suggested that Cdc73 might regulate mRNA processing by facilitating the recruitment of 3′ factors to transcribed loci. Other evidence of PAF involvement in 3′ processing comes from yeast, where PAF was shown to affect poly (A) tail length ([@b34-molcell-37-9-644]) and poly (A) site selection ([@b40-molcell-37-9-644]). In addition, another study ([@b35-molcell-37-9-644]) found a role of PAF in mediating stimulation of 3′ processing by transcriptional activators, confirming its potential role in bridging polyadenylation to transcription ([Fig. 3B](#f3-molcell-37-9-644){ref-type="fig"}). It is, however, significant that none of the other five subunits of the PAF complex, only Cdc73, co-purified with the 3′ complex in the proteomic study ([@b48-molcell-37-9-644]), suggesting that Cdc73 might play a PAF-independent role in 3′ processing.

Another RNA pol II associated complex that was found to associate with the 3′ processing machinery is the Integrator. The Integrator mediates 3′ processing of U1 and U2 small nuclear RNAs (snRNAs) ([@b4-molcell-37-9-644]), and several reports have emerged that suggest this complex might be multifunctional and play roles in various types of gene expression regulation beyond snRNA ([@b22-molcell-37-9-644]; [@b53-molcell-37-9-644]; [@b66-molcell-37-9-644]). Since almost all components of this complex were found in the proteomic analysis, it is very likely that the Integrator might have a yet undiscovered function in mRNA 3′ end formation as well.

Another interesting connection that stems from the proteomic analysis involves the NEXT complex ([@b29-molcell-37-9-644]). NEXT is a multisubunit complex that is required for exosome-mediated degradation of noncoding RNAs such as promoter upstream transcripts (PROMPTs, also known as upstream antisense RNAs, uaRNAs), which are processed by the canonical 3′ cleavage machinery ([@b1-molcell-37-9-644]; [@b37-molcell-37-9-644]) but targeted for rapid degradation by an unknown mechanism (Richard and Manley, 2013). It is surprising that the three NEXT subunits, MTR4, ZCCHC8 and RBM7, were all found to associate with the 3′ complex ([@b48-molcell-37-9-644]). This could mean that NEXT might be involved in degradation of certain newly synthesized mRNAs, or other Pol II transcripts such as PROMPTs, by recruiting the exosome via interaction with the 3′ processing machinery. This might be similar to what occurs with the yeast TRAMP complex, which was shown to function in mRNA quality control by interacting with components of the exosome and stimulating degradation of aberrant mRNAs ([@b50-molcell-37-9-644]). In fact some of the canonical exosome components were found as well in the proteomic analysis of the 3′ processing complex, including the catalytic subunit exosome10 (also known as Rrp6) and a number of non-catalytic subunits. The significance of these interactions will be an important topic for future study.

Finally, links between DNA damage response factors and the 3′ processing complex are especially intriguing. Previous studies have described similar connections, showing that 3′ processing is inhibited following DNA damage, concomitantly with an increased interaction between CstF50 and the BARD/BRCA1 complex ([@b24-molcell-37-9-644], [@b25-molcell-37-9-644]). This interaction was later shown also to stimulate the deadenylation activity of PARN (poly(A)-specific ribonuclease) during DNA damage, leading to RNA degradation ([@b6-molcell-37-9-644]). In addition, p53 also interacts with CstF50 and BARD1 and has an inhibitory effect on 3′ processing of housekeeping genes following UV treatment ([@b36-molcell-37-9-644]).

The proteomic study mentioned above identified DNA-PK as associated with the pre-mRNA 3′ processing complex. DNA-PK is a nuclear serine/threonine kinase that is comprised of a regulatory subunit, containing the Ku70/86 components, and a catalytic subunit, DNA-PK~cs~; interestingly, all of these subunits were found to associate with the 3′ complex. DNA-PK is a molecular sensor for DNA damage: it is involved in DNA nonhomologous end joining and is required for double-strand break (DSB) repair and VDJ recombination (reviewed in [@b8-molcell-37-9-644]). DNA-PK must be bound to DNA to express its catalytic properties, but the fact that it is associated with the 3′ complex raises the possibility that RNA might activate it as well. It will be important to understand if DNA-PK functions to somehow connect the cellular response to DSBs to 3′ processing or if it has a separate function in the maturation of mRNA 3′ ends. One way to test this could be by using one of the several small molecule inhibitors of DNA-PK ([@b9-molcell-37-9-644]), and determine whether it affects 3′ cleavage activity, either in the presence or absence of DNA damage. It is likely that one of the 3′ processing factors might be a target for phosphorylation by DNA-PK as several 3′ factors are known to be phosphorylated (reviewed in [@b44-molcell-37-9-644]) but in most cases the kinase is unknown. Interestingly DNA-PK was shown also to phosphorylate and modulate PARP1 activity ([@b2-molcell-37-9-644]), another protein related to DNA damage that was identified in association with the 3′ complex.

PARP1 is an enzyme that catalyzes the post-translational modification known as Poly(ADP-ribosyl)ation (PARylation). PARP1 is known to take part in several cellular processes, including DNA damage detection and repair, chromatin modification and transcription (reviewed in [@b19-molcell-37-9-644]; [@b26-molcell-37-9-644]). Establishing the significance of the association of PARP1 with the 3′ processing complex, PARP1 was recently shown to PARylate PAP and to inhibit its activity in vitro ([@b11-molcell-37-9-644]). In vivo the modification can be detected after heat shock treatment, but not after activating PARP1 with IR radiation or H~2~O~2~. PARylation of PAP leads to polyadenylation inhibition due to the decreased ability of modified PAP to bind RNA ([Fig. 3C](#f3-molcell-37-9-644){ref-type="fig"}). Interestingly, a recent proteome-wide study showed that activation of PARP1 by H~2~O~2~ and MMS (but not by UV or IR radiation) leads to PARylation of several other 3′ processing factors such as PABPN1 and all CPSF subunits ([@b21-molcell-37-9-644]), pointing to the possibility that PARP1 might be a general regulator of 3′ processing under a variety of conditions. For the future it would be very interesting to understand what determines the specificity of this regulation; for example, activation of PARP1 by different genotoxic stimuli might cause it to interact with different protein partners, which might then direct its enzymatic activity toward different targets.

In summary, it is becoming evident that the 3′ processing machinery is even more complex than previously thought. The need to connect polyadenylation with many cellular pathways such as transcription, splicing, cell cycle control and DNA damage, might explain why such an immense machinery is involved in regulating this relatively simple reaction. Coordination between the different steps of gene expression is critical for proper cellular function, and future studies need to focus on understanding in more detail the roles of the proteins discussed above.
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![The pre-mRNA 3′ processing complex. The core 3′ processing complex is composed of four multisubunit subcomplexes: CPSF, CstF, CFI and CFII together with additional factors such as symplekin, the CTD of RNA pol II and PAP. This machinery recognizes cis-elements within the pre-mRNA: CPSF binds to the AAUAAA sequence located upstream of the cleavage site (marked here with a black arrow), CstF recognizes G/U-rich elements downstream of the cleavage site and CFI binds the auxiliary sequence UGUA located upstream of AAUAAA.](molcell-37-9-644f1){#f1-molcell-37-9-644}

![Connecting 3′ process-ing with multiple nuclear pathways. WDR33, PP1 and RBBP6 are recently discovered 3′ processing factors that function in regulation of cleavage and polyadenylation. Additional proteins, as depicted in the figure, interact with the 3′ complex and function in connecting pre-mRNA 3′ processing with other nuclear pathways such as RNA quality control, splicing, transcription and DNA damage.](molcell-37-9-644f2){#f2-molcell-37-9-644}

![Examples of 3′ processing regulation. (A) Isoform1 (iso1) of RBBP6 is required for efficient 3′ cleavage and associates with CstF through its DWNN domain. Isoform3 (iso3) of RBBP6, which is composed of the DWNN motif only and is downregulated in several human cancers, competes with iso1 for binding to CstF and inhibits 3′ processing. (B) PAF recruitment to promoter regions facilitates coordination of poly (A) factors with the transcription elongation complex, which results in enhanced efficiency of 3′ end formation. (C) During heat shock PARP1 PARylates PAP and causes its dissociation from 3′ ends of non-heat shock protein transcripts, resulting in polyadenylation inhibition.](molcell-37-9-644f3){#f3-molcell-37-9-644}
